$センティ・バイオサイエンシズ(SNTI.US)$Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
$センティ・バイオサイエンシズ(SNTI.US)$Reuters· 2 mins ago Senti Bio Announces Publication of Senti-202 Preclinical Data Demonstrating Potential of Logic-Gated Car-Nk Cell Therapy for the Treatment of Acute Myeloid Leukemia (Aml)
$センティ・バイオサイエンシズ(SNTI.US)$ NEWS Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
センティ・バイオサイエンシズに関するコメント
A bit more
Update
Senti Bio Announces Publication of Senti-202 Preclinical Data Demonstrating Potential of Logic-Gated Car-Nk Cell Therapy for the Treatment of Acute Myeloid Leukemia (Aml)
NEWS
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
Strong pipeline
$センティ・バイオサイエンシズ(SNTI.US)$
are you serius invest to here🧐 ??
let's go, move up, time waster.
There is no reason why this thing ain’t hitting a dollar about sick of the scam stocks scamming people out there money
weird drop on good news.
まだコメントはありません